BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18052709)

  • 1. CCL28 effects on periodontal pathogens.
    Watkins HR; Lapp CA; Hanes PJ; Dickinson DP; Volkmann KR; Newman CL; Konzelman JL
    J Periodontol; 2007 Dec; 78(12):2356-63. PubMed ID: 18052709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of naringin on the growth of periodontal pathogens in vitro.
    Tsui VW; Wong RW; Rabie AB
    Phytother Res; 2008 Mar; 22(3):401-6. PubMed ID: 18167053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human salivary cystatin SA exhibits antimicrobial effect against Aggregatibacter actinomycetemcomitans.
    Ganeshnarayan K; Velliyagounder K; Furgang D; Fine DH
    J Periodontal Res; 2012 Oct; 47(5):661-73. PubMed ID: 22582873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of the effect of essential oil-containing oral strips on salivary bacteria using the checkerboard method.
    da Silva CM; Colombo AV; do Souto RM; Colombo AP
    J Clin Dent; 2005; 16(2):38-43. PubMed ID: 16170974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells.
    Jiang Y; Graves DT
    J Periodontol; 1999 Dec; 70(12):1472-8. PubMed ID: 10632523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of quercetin on periodontal pathogens in vitro.
    Geoghegan F; Wong RW; Rabie AB
    Phytother Res; 2010 Jun; 24(6):817-20. PubMed ID: 19957242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of quercetin on periodontal pathogens.
    Geoghegan F; Tsui VW; Wong RW; Rabie AB
    Ann R Australas Coll Dent Surg; 2008 Jun; 19():157-8. PubMed ID: 22073470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.
    Eick S; Pfister W
    J Periodontol; 2004 Oct; 75(10):1327-34. PubMed ID: 15562909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro sensitivity of oral gram-negative bacteria to the bactericidal activity of defensins].
    Zhong D; Yang M; Zhang Y; Wu Q; Wang B; Li C; Yu R
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1998 Feb; 16(1):26-8. PubMed ID: 12078176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.
    Hieshima K; Ohtani H; Shibano M; Izawa D; Nakayama T; Kawasaki Y; Shiba F; Shiota M; Katou F; Saito T; Yoshie O
    J Immunol; 2003 Feb; 170(3):1452-61. PubMed ID: 12538707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ozone against periodontal pathogenic microorganisms.
    Huth KC; Quirling M; Lenzke S; Paschos E; Kamereck K; Brand K; Hickel R; Ilie N
    Eur J Oral Sci; 2011 Jun; 119(3):204-10. PubMed ID: 21564314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol inhibits periodontal pathogens in vitro.
    O'Connor DJ; Wong RW; Rabie AB
    Phytother Res; 2011 Nov; 25(11):1727-31. PubMed ID: 21520308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria.
    Mineshiba F; Takashiba S; Mineshiba J; Matsuura K; Kokeguchi S; Murayama Y
    J Int Acad Periodontol; 2003 Apr; 5(2):35-40. PubMed ID: 12760504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.
    Eick S; Seltmann T; Pfister W
    J Clin Periodontol; 2004 May; 31(5):376-83. PubMed ID: 15086620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction.
    Boutaga K; Savelkoul PH; Winkel EG; van Winkelhoff AJ
    J Periodontol; 2007 Jan; 78(1):79-86. PubMed ID: 17199543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease.
    Ardila CM; López MA; Guzmán IC
    Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e947-51. PubMed ID: 20383102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic effects of hyaluronic acid.
    Pirnazar P; Wolinsky L; Nachnani S; Haake S; Pilloni A; Bernard GW
    J Periodontol; 1999 Apr; 70(4):370-4. PubMed ID: 10328647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL28 involvement in mucosal tissues protection as a chemokine and as an antibacterial peptide.
    Berri M; Virlogeux-Payant I; Chevaleyre C; Melo S; Zanello G; Salmon H; Meurens F
    Dev Comp Immunol; 2014 Jun; 44(2):286-90. PubMed ID: 24445014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone powder enhances the effectiveness of bioactive glass S53P4 against strains of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in suspension.
    Waltimo T; Zehnder M; Söderling E
    Acta Odontol Scand; 2006 Jun; 64(3):183-6. PubMed ID: 16809197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial activity of Prevention mouthrinse.
    Drake DR; Wefel JS; Dunkerson D; Hogle K
    Am J Dent; 1993 Oct; 6(5):239-42. PubMed ID: 7880467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.